CN1261886A - 8－氯－6,11－二氢－11－(4－亚哌啶基)－5H－苯并[5,6]环庚[1,2－b]吡啶的多晶型体 - Google Patents

8－氯－6,11－二氢－11－(4－亚哌啶基)－5H－苯并[5,6]环庚[1,2－b]吡啶的多晶型体 Download PDF

Info

Publication number
CN1261886A
CN1261886A CN98806712A CN98806712A CN1261886A CN 1261886 A CN1261886 A CN 1261886A CN 98806712 A CN98806712 A CN 98806712A CN 98806712 A CN98806712 A CN 98806712A CN 1261886 A CN1261886 A CN 1261886A
Authority
CN
China
Prior art keywords
polymorphs body
vwd
crystallization
dcl
polymorphs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98806712A
Other languages
English (en)
Chinese (zh)
Inventor
D·P·舒马彻尔
J·李
L·R·罗杰斯
C·G·埃克哈特
N·S·萨旺特
M·B·米切尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25389724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1261886(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of CN1261886A publication Critical patent/CN1261886A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN98806712A 1997-07-02 1998-07-01 8－氯－6,11－二氢－11－(4－亚哌啶基)－5H－苯并[5,6]环庚[1,2－b]吡啶的多晶型体 Pending CN1261886A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88676697A 1997-07-02 1997-07-02
US08/886,766 1997-07-02

Publications (1)

Publication Number Publication Date
CN1261886A true CN1261886A (zh) 2000-08-02

Family

ID=25389724

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98806712A Pending CN1261886A (zh) 1997-07-02 1998-07-01 8－氯－6,11－二氢－11－(4－亚哌啶基)－5H－苯并[5,6]环庚[1,2－b]吡啶的多晶型体

Country Status (25)

Country Link
EP (1) EP0993455B1 (https=)
JP (2) JP2002507991A (https=)
KR (1) KR20010014316A (https=)
CN (1) CN1261886A (https=)
AR (1) AR013161A1 (https=)
AT (1) ATE239010T1 (https=)
AU (1) AU734487B2 (https=)
BR (1) BR9811658A (https=)
CA (1) CA2294352C (https=)
CO (1) CO4940423A1 (https=)
DE (1) DE69814076T2 (https=)
ES (1) ES2197480T3 (https=)
HU (1) HUP0004308A3 (https=)
IL (1) IL133387A (https=)
MY (1) MY132943A (https=)
NO (1) NO996547L (https=)
NZ (1) NZ501417A (https=)
PE (1) PE86399A1 (https=)
PL (1) PL337712A1 (https=)
RU (1) RU2197485C2 (https=)
SK (1) SK185299A3 (https=)
TR (1) TR199903308T2 (https=)
UA (1) UA62976C2 (https=)
WO (1) WO1999001450A1 (https=)
ZA (1) ZA985783B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103755682A (zh) * 2013-12-30 2014-04-30 山东达因海洋生物制药股份有限公司 一种地氯雷他定新晶型及制备方法
CN108358892A (zh) * 2018-04-11 2018-08-03 常州方圆制药有限公司 一种地氯雷他定粗品的提纯方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7678908B2 (en) * 2002-04-15 2010-03-16 Sun Pharmaceutical Industries Limited Process of preparing desaloratadine
WO2004012738A1 (en) * 2002-08-05 2004-02-12 Sandoz Ag Novel salt and polymorphs of desloratadine hemifumarate
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
WO2004080461A2 (en) * 2003-03-12 2004-09-23 TEVA Gyógyszergyár Részvénytársaság Stable pharmaceutical compositions of desloratadine
SK50112007A3 (sk) * 2004-07-07 2007-07-06 Egis Gy�gyszergy�r Nyrt. Nový pseudopolymorf desloratadínu vytvorený s oxidom uhličitým
TW200735871A (en) * 2005-11-17 2007-10-01 Teva Pharma Desloratadine crystalline forms mixtures having a low level of residual solvents
HU230417B1 (hu) * 2006-10-26 2016-05-30 Egis Gyógyszergyár Zrt Eljárás desloratadine szén-dioxiddal képezett adduktjának előállítására
EP2164470A1 (en) * 2007-05-11 2010-03-24 ratiopharm GmbH Pharmaceutical composition comprising desloratadine
EP2269586B1 (en) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising desloratadine
PT2568970T (pt) 2010-05-10 2019-02-11 Lesvi Laboratorios Sl Formulações farmacêuticas estáveis contendo um anti-histamínico
EP2727592A1 (en) 2012-11-05 2014-05-07 Kücükgüzel, Sükriye Güniz A combination of desloratadine and paracetamol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
EP0208855B1 (en) * 1985-05-13 1991-03-06 Schering Corporation process for preparing piperidylidene dihydrodibenzo(a,d)cycloheptenes and aza derivatives thereof, compounds obtained by such process and the use of such compounds for preparing useful pharmaceutical compositions
IE68935B1 (en) * 1990-06-22 1996-07-24 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103755682A (zh) * 2013-12-30 2014-04-30 山东达因海洋生物制药股份有限公司 一种地氯雷他定新晶型及制备方法
CN108358892A (zh) * 2018-04-11 2018-08-03 常州方圆制药有限公司 一种地氯雷他定粗品的提纯方法

Also Published As

Publication number Publication date
HUP0004308A3 (en) 2004-07-28
EP0993455A1 (en) 2000-04-19
DE69814076T2 (de) 2004-02-26
SK185299A3 (en) 2000-07-11
AR013161A1 (es) 2000-12-13
PL337712A1 (en) 2000-08-28
PE86399A1 (es) 1999-10-23
ES2197480T3 (es) 2004-01-01
ATE239010T1 (de) 2003-05-15
BR9811658A (pt) 2000-09-05
UA62976C2 (en) 2004-01-15
HUP0004308A2 (hu) 2001-10-28
MY132943A (en) 2007-10-31
JP2002507991A (ja) 2002-03-12
CO4940423A1 (es) 2000-07-24
NO996547L (no) 2000-03-01
ZA985783B (en) 1999-01-19
AU8271098A (en) 1999-01-25
NZ501417A (en) 2000-10-27
NO996547D0 (no) 1999-12-29
TR199903308T2 (xx) 2000-11-21
KR20010014316A (ko) 2001-02-26
WO1999001450A1 (en) 1999-01-14
IL133387A (en) 2004-02-08
DE69814076D1 (de) 2003-06-05
HK1024687A1 (en) 2000-10-20
AU734487B2 (en) 2001-06-14
JP2009242436A (ja) 2009-10-22
IL133387A0 (en) 2001-04-30
CA2294352A1 (en) 1999-01-14
CA2294352C (en) 2008-05-06
RU2197485C2 (ru) 2003-01-27
EP0993455B1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
CN1261886A (zh) 8－氯－6,11－二氢－11－(4－亚哌啶基)－5H－苯并[5,6]环庚[1,2－b]吡啶的多晶型体
JP7721712B2 (ja) Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用
CN1191242C (zh) 不同结晶型的(－)－6－氯－4－环丙乙炔基－4－三氟甲基－1,4－二氢－2h－3,1－苯并噁嗪－2－酮
CN1290843C (zh) 4－[2－[4－[1－(2－乙氧基乙基)－1H－苯并咪唑－2－基]－1－哌啶基]乙基]－α,α－二甲基苯乙酸的多晶型物
CN1155886A (zh) 抗周期性偏头痛的吲哚衍生物盐
CN1181064C (zh) 结晶形式的n－(4－三氟甲基苯基)－5－甲基异噁唑－4－甲酰胺的制备方法
CN1217720A (zh) 苯并呋喃基衍生物及其应用
EA022343B1 (ru) Способ получения мелких частиц безводных кристаллов b арипипразола
CN1281453A (zh) 作为药物的5－[4－[2－(n－甲基－n－(2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮马来酸盐的水合物
CN1039421A (zh) 利福喷丁氢卤化物
JP4653979B2 (ja) 結晶化を介するモキシデクチンの精製方法
CN1136196C (zh) 3-(2,4-二氯苄基)-2-甲基-n-(戊磺酰基)-3h-苯并咪唑-5-羧酰胺的晶形
CN1314888A (zh) 奥沙奈丹的晶型
JP2008520751A (ja) 大粒子サイズを有するタダラフィル及びそれを調製する方法
JP2006321798A (ja) 医薬組成物のために好適な高純度のテルミサルタン型ａを製造するための改良された方法
JP2006521340A (ja) ロシグリタゾン・マレイン酸塩の多形体の製法
US8044038B2 (en) Crystallization process of quetiapine hemifumarate
CN1761658A (zh) 制备氰基－异苯并呋喃的方法
JPH10182641A (ja) ドキサゾシン・メシレートの新規な形態ｉｉｉ
EP3002286B1 (en) Preparation method for polymorphic 6-(4-chlorophenoxy)-tetrazolo[5,1-a]phthalazine and use thereof
DE69907467T2 (de) Verfahren zur herstellung von einer nicht-kristallinen wasswerfreien form von paroxetin hydrochlorid
CN100345846C (zh) 5－[4－[2－(n－甲基－n－(2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮的钠盐
PL207322B1 (pl) Sposób wytwarzania zaleplonu
JP4732361B2 (ja) 塩酸１−シクロプロピル−７−（（ｓ，ｓ）−２，８−ジアザジシクロ（４．３．０）ノン−８−イル）−６−フルオロ−１，４−ジヒドロ−８−メトキシ−４−オキソ−３−キノリンカルボン酸の多形およびその調製方法
CN1882566A (zh) (+)－和(－)－赤型－甲氟喹盐酸盐的晶形

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication